Skip to content
★ Sign in to follow
AR

Adam Rogers

Shareholder
NervGen Pharma Corp.
Total declarations
11
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 08 Jul 2026 for NervGen Pharma Corp., €138k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Adam Rogers: trading record in brief

This profile gathers the share dealings of Adam Rogers in NervGen Pharma Corp. Over a trading history stretching from 13 July 2022 to 30 June 2026, the count stands at 11 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 8 July 2026, the filings show a share grant worth €138k in NervGen Pharma Corp. Filings reach the SEDI feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Adam Rogers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◆
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    224,635 CAD19SEDI
    61,713 shares@ CA$3.640.036% mcap2.3% of flowCommon SharesTSXSEDI:4748874
  • ◆
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    137,534 CAD18SEDI
    37,784 shares@ CA$3.640.022% mcap1.4% of flowCommon SharesTSXSEDI:4748871
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    3M CAD0SEDI
    800,000 shares@ CA$3.6829.8% of flowWarrantsTSXSEDI:4727977
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    2M CAD13SEDI
    800,000 shares@ CA$2.5020.3% of flowCommon SharesTSXSEDI:4727973
  • ◇
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    5M CAD0SEDI
    1,146,108 shares@ CA$3.9946.3% of flowOptionsTSXSEDI:4725769
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    2M CAD12SEDI
    952,381 shares@ CA$2.1014.5% of flowCommon SharesTSXSEDI:4608080
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    2M CAD12SEDI
    857,143 shares@ CA$2.1013.1% of flowCommon SharesTSXSEDI:4608092
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    0SEDI
    Common SharesTSXSEDI:4608090
  • ◇
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    17,400 CAD11SEDI
    10,000 shares@ CA$1.740.1% of flowCommon SharesTSXSEDI:4513203
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    0SEDI
    Common SharesTSXSEDI:3979893
  • ●
    4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security HolderExecutivesNervGen Pharma Corp.
    0SEDI
    Common SharesTSXSEDI:3979890

11 of 11 declarations